The enhancement of neutron irradiation of HeLa-S cervix carcinoma cells by cell-nucleus-addressed deca-p-boronophenylalanine

European Journal of Medicinal Chemistry

Volumn 38, Issue 6, 2003, Pages 587-595

  Braun, Klaus ^a   Wolber, Gerd ^a   Waldeck, Waldemar ^a   Pipkorn, Rüdiger ^a   Jenne, Jürgen ^a   Rastert, Ralf ^a   Ehemann, Volker ^b   Eisenmenger, Andreas ^a   Corban Wilhelm, Heike ^a   Braun, Isabell ^c   Heckl, Stefan ^a   Debus, Jürgen ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Bioshuttle; Boron neutron capture therapy (BNCT); Boronophenylalanine (BPA); Drug delivery; LET effects; Nuclear transport

Indexed keywords

BORON; DECA 4 BORONOPHENYLALANINE; HELIUM; LITHIUM; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ARTICLE; CANCER RADIOTHERAPY; CELL DEATH; CELL KILLING; CELL NUCLEUS; DNA DAMAGE; DRUG DELIVERY SYSTEM; FLOW CYTOMETRY; HELA CELL; HUMAN; HUMAN CELL; LINEAR ENERGY TRANSFER; NEUTRON CAPTURE THERAPY; NEUTRON RADIATION; NUCLEAR REACTOR; NUCLEOTIDE SEQUENCE; RADIATION DOSE; RADIATION MEASUREMENT; UTERINE CERVIX CARCINOMA;

EID: 10744228953     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(03)00088-6     Document Type: Article

References (26)

1. Utsumi H., Ichihashi M., Kobayashi T., Elkind M.M. Sublethal and potentially lethal damage repair on thermal neutron capture therapy. Pigment Cell Res. 2:1989;337-342.
2. Santin A.D., Hermonat P.L., Ravaggi A., Chiriva-Internati M., Pecorelli S., Parham G.P. Radiation-enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma. Cancer. 83:1998;2346-2352.
3. Locher G.L. Biological effects and therapeutic possibilities of neutrons. Am. J. Roentgenol. Radiat. Ther. 36:1936;1-13.
4. Coderre J.A., Morris G.M. The radiation biology of boron neutron capture therapy. Radiat. Res. 151:1999;1-18.
5. Slatkin D.N. A history of boron neutron capture therapy of brain tumors - postulation of a brain radiation dose tolerance limit. Brain. 114:1991;1609-1610.
6. Coderre J.A. Radiation oncology. Leibel S.A., Phillips T.L. Textbook of Radiation Oncology. 1998;1263-1277 W. B. Saunders, Philadelphia.
7. Hatanaka H. Boron-neutron capture therapy for tumors. Karim A.B.M.F., Laws E.R. Glioma. 1991;233-249 Springer, Berlin.
8. 7Li reaction in HeLa cells. Radiat. Res. 43:1970;534-553.
9. Javia M., Brownell G.L., Sweet W.H. The possible use of neutron-capturing isotopes such as boron10 in the treatment of neoplasms. II. Computation of the radiation energies and estimates of effects in normal and neoplastic brain. J. Clin. Invest. 31:1952;604-610.
10. Tolpin E.I., Wellum G.R., Dohan F.C. Jr., Kornblith P.L., Zamenhof R.G. Boron neutron capture therapy of cerebral gliomas. II. Utilization of the blood-brain barrier and tumor-specific antigens for the selective concentration of boron in gliomas. Oncology. 32:1974;223-246.
11. Wazer D.E., Zamenhof R.G., Harling O.K., et al. Boron neutron capture therapy. March P.M., Loeffler J.S. Radiation Oncology Technology and Biology. 1994;167-191 W. B. Saunders, Philadelphia.
12. Ono K., Kinashi Y., Masunaga S., Suzuki M., Takagaki M. Electroporation increases the effect of borocaptate (10B-BSH) in neutron capture therapy. Int. J. Radiat. Oncol. Biol. Phys. 42:1998;823-826.
13. Bauer C., Gabel D., Dörfler U. Azanonaboranes [(RNH2B8H11NHR] as possible new compounds for use in boron neutron capture therapy. Eur. J. Med. Chem. 37:2002;649-657.
14. Braun K., Peschke P., Pipkorn R., Lampel S., Wachsmuth M., Waldeck W., Friedrich E., Debus J. A biological transporter for the delivery of peptides to the nuclear compartment in living cells. J. Mol. Biol. 318:2002;237-243.
15. Paquet A. Introduction of 9-fluorenylmethyloxycarbonyl, trichloroethoxycarbonyl, and benzyloxycarbonyl amine protecting groups into O-unprotected hydroxyamino acids using succinimidyl carbonates. Can. J. Chem. 60:1982;976-980.
16. Fields C.G., Lloyd D.H., MacDonald R.L., Ottesan K.H., Noble R.L. HBTU activation for automated Fmoc-solid-phase peptide synthesis. Pept. Res. 4:1991;95-101.
17. Wolber G., Hoever K.H., Krauss O., Maier-Borst W. A new fast-neutron source for radiobiological research. Phys. Med. Biol. 42:1997;725-733.
18. K.H. Beckurts, K. Wirtz, Neutron Physics, Springer Verlag, Berlin, Göttingen, Heidelberg, New York, 1964. Library of Congress Catalog Card Number 64-25646.
19. K.H. Hoever, Masters Thesis (Diplomarbeit), University of Heidelberg and DKFZ, 1971.
20. Nias A.H.W., Greene D., Fox M., et al. Effect of 14 MeV monoenergetic neutrons on HeLa and P388F cells in vitro. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 13:1967;449.
21. G. Wolber, K. Braun, A. Eisenmenger, T. Sobkowiak, A. Bankamp, W. Semmler, Untersuchungen zur Bor-Neutronen-Einfang-Therapie (BNCT) in Feldern schneller Neutronen, in: K. Welker, K. Zink, (Eds.), Medizinische Physik., Berlin, 2001, pp. 273-274.
22. Ehemann V., Hashemi B., Lange A., Otto H.F. Flow cytometric DNA analysis and chromosomal aberrations in malignant glioblastomas. Cancer Lett. 138:1999;101-106.
23. Hampson L., El Hady E.S., Moore J.V., Kitchener H., Hampson I.N. The HPV16 E6 and E7 proteins and the radiation resistance of cervical carcinoma. FASEB J. 15:2001;1445-1447.
24. Loken M.R. Immunofluorescence techniques. Melamed M.R., Lindmo T., Mendelsohn M.L. Flow Cytometry and Cell Sorting. 2nd ed. 1990;341-353 Wiley-Liss Inc, New York. Chapter 17.
25. Kreimann E.L., Itoiz M.E., Dagrosa A., Garavaglia R., Farias S., Batistoni D., Schwint A.E. The hamster pouch as a model of oral cancer for boron neutron capture therapy studies: selective delivery of boron by boronophenylalanine. Cancer Res. 61:2001;8775-8781.
26. Heckl S., Debus J., Jenne J., Pipkorn R., Waldeck W., Spring H., Rastert R., von der Lieth C.W., Braun K. CNN-Gd(3+) enables cell nucleus molecular imaging of prostate cancer cells: the last 600 nm. Cancer Res. 62:2002;7018-7024.